Advertisement
U.S. markets closed

VKTX Nov 2024 48.000 call

OPR - OPR Delayed Price. Currency in USD
5.200.00 (0.00%)
As of 12:12PM EST. Market open.
Full screen
Previous Close5.20
Open3.23
Bid3.00
Ask6.60
Strike48.00
Expire Date2024-11-22
Day's Range3.23 - 5.20
Contract RangeN/A
Volume14
Open Interest17
  • Motley Fool

    3 Monster Stocks in the Making

    Here's why they think biotech stocks CRISPR Therapeutics (NASDAQ: CRSP), Summit Therapeutics (NASDAQ: SMMT), and Viking Therapeutics (NASDAQ: VKTX) could become much larger. David Jagielski (CRISPR Therapeutics): If you're looking for stocks with mammoth upside, you might be tempted to look for risky stocks that don't have any approved drugs or treatments yet. In December 2023, regulators approved Casgevy, which is a gene-editing therapy the company has been developing with Vertex Pharmaceuticals.

  • Investor's Business Daily

    RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?

    Robert F. Kennedy Jr.'s potential appointment to HHS has spooked Eli Lilly stock and stocks tied to popular weight-loss drugs.